Xencor Inc (XNCR) financials

NASDAQ · Health Care

$29.82 +2.09% Close Oct 30, 2026 Live

Xencor revenue and earnings by year

Xencor's revenue was $126 million in the fiscal year to December 31, 2025, up 13.7% from the year before. Net income was -$91.9 million, -73.2% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 1.6% a year on average.

RevenueNet income
-$200M$0$200M
2016201720182019202020212022202320242025

Fiscal years, each labelled by the calendar year it ended in.

Income statement, the last 10 fiscal years

In millions of US dollars except per-share figures. Each column is a fiscal year, named by the month it ended.
Fiscal year toDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
Revenue1261101751652751231574146109
Revenue growth13.7%-36.7%6.1%-40.2%124.2%-21.7%285.9%-12.0%-57.7%—
Operating income-178-178-132-8244-7714-79-4344
Operating margin-141.4%-161.5%-75.8%-50.1%15.9%-62.6%8.8%-195.5%-93.4%40.4%
Net income-92-233-133-5583-6927-70-3845
Net margin-73.2%-210.5%-76.2%-33.5%30.0%-56.5%17.2%-173.4%-83.4%41.4%
Diluted EPS-$1.24-$3.58-$2.20-$0.93$1.37-$1.21$0.45-$1.35-$0.83—
Free cash flow-138-208-96-14-30-1657-87-3994

Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open XNCR in Markets.

How Xencor makes money

Revenue by segment in the quarter to June 30, 2026, as the company reports it.

SegmentRevenueShare
Royalty$41.2M80.5%
Milestone$10.0M19.5%

See also: XNCR returns

No forecast, no recommendation. This page describes Xencor Inc from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.